lobbying_activities: 1297989

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1297989	13eccf36-2b62-4111-9d4d-80814c82d4fb	Q3	PHARMAVITE LLC	286074	PHARMAVITE LLC	2012	third_quarter	FOO	New Dietary Ingredient regulation from FDA and the negative impact of the rule if not modified Concern over shrinking FDA budget and its impact on GMP compliance Concern about adequacy of GMPs and the impact of Senator Durbin's inquiries on caffeine and supplement labeling Updates on Pharmavite manufacturing expansion	HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2012-10-12T16:39:31.123000-04:00